- Home
- / PreveCeutical Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PreveCeutical Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$13.5 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 15.0K | 3.0K | |||||
| Cost of goods sold | 5.0K | 1.0K | |||||
| Gross profit | 14.0K | 67.0K | 23.0K | ||||
| Gross profit margin, % | 2233.3% | ||||||
| Operating expense total | 6.0M | 2.8M | 1.8M | 500.0K | 687.0K | 952.0K | 803.0K |
| Depreciation and amortization | 36.0K | 174.0K | 75.0K | 5.0K | 10.0K | 10.0K | 10.0K |
| EBITDA | (6.0M) | (2.7M) | (1.7M) | (500.0K) | (687.0K) | (952.0K) | (803.0K) |
| EBITDA margin, % | -90633.3% | ||||||
| EBIT | (8.0M) | (2.6M) | (3.4M) | (1.0M) | (874.0K) | (962.0K) | (813.0K) |
| EBIT margin, % | -86200.0% | ||||||
| Interest expense | 209.0K | 233.0K | 183.0K | 138.0K | 207.0K | 310.0K | 327.0K |
| Pre tax profit | (11.9M) | (3.6M) | (3.8M) | (1.7M) | (1.5M) | (1.3M) | (1.2M) |
| Income tax expense | (40.0K) | (8.0K) | (6.0K) | (20.0K) | |||
| Net Income | (11.9M) | (3.6M) | (3.8M) | (1.7M) | (1.5M) | (1.3M) | (1.2M) |